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osting by EAbstract Background: Epidermodysplasia verruciformis (EV) is a well known inherited autoso-
mal recessive skin disease associated with numerous early onset viral warts on the sun exposed parts
of the body that usually progress into skin malignancies. Kidney transplant patients are also com-
monly associated with viral warts that might change into skin cancers.
Objective: To describe the clinical pictures of extensive viral warts with skin malignancies in kidney
transplant patients in comparison with inherited (EV) features.
Patients and methods: This case controlled study that included130patientswithkidney transplantation
was done in kidney transplantation centers in Baghdad and Al-Karma Teaching Hospitals during
December 2002 to September 2004. All recruited patients were receiving multiple immunosuppressive
drugs like methyl prednisolone succinate, oral prednisolone, azathioprine and cyclosporine. History
was taken fromall patients includingall the relevantpoints.Thesepatientsweredivided into threegroups
according to the duration of kidney transplant: group A 1–10 years, group B 11–20 years and group C
more than 20 years. Biopsies were performed from the viral warts lesions and the associated tumors.
Twohundredandsixtyapparentlyhealthy individuals,206malesand54femaleshadbeenexaminedas
control cases for the presence of viral warts and tumors. These control cases had been taken randomly
from general population in multiple regions in Baghdad.ntiﬁc Council of Dermatology
ical Specializations, Medical
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54 K.E. Sharquie et al.Results: Sixty-ﬁve patients out of 130 with kidney transplantation had viral warts. Their ages ranged
from20 to 71 (45.49 ± SD10.82) years, 51males and 14 females, while the duration of the warts ranged
from0.5 to10 (3.74 ± SD2.67) years.Thedistributionofpatientswithviralwarts among the groupswas
as follows: groupA 28 (43.1%), groupB 30 (46.2%) and groupC 7 (10.7%) cases.Viralwartswere seen in
10 (3.8%) of the control group. There were statistically signiﬁcant differences between patients and con-
trol cases (P value<0.001).Most of the viralwarts in patientswith kidney transplantationweremultiple
and of the verrucae vulgaris type. They weremainly located on the exposed areas of the body, mostly on
the face and dorsa of hands.
Skinmalignancieswereobserved in6 (9.2%)cases:ﬁvesquamouscell carcinomasandonecaseofbasal
cell carcinoma. Squamous cell carcinoma was mainly located on the lower lips in 3 cases and 2 on the
dorsa of hands,while basal cell carcinomawas observed on the nose. Two cases (7.1%)of squamous cell
carcinoma were seen in group A, 2 (6.6%) in group B and 1 (14%) in group C. One case of basal cell car-
cinoma was noted in group B .No skin malignancy was observed in the control group.
Conclusion: Kidney transplant patients have an increased susceptibility to infection with human papil-
loma virus and have served as a model for viral induced carcinogenesis. This collection of features
deserves the term ‘‘acquired epidermodysplasia verruciformis’’.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Epidermodysplasia verruciformis (EV) is an inherited
autosomal recessive gene disorder in which there is early
onset, numerous, widespread, persistent, and refractory
infection with human papilloma virus (HPV) (Sterling and
Kurtz, 1998; Penneys, 1997; Lowy et al., 2003; Odom et al.,
2000).
The individual lesions typically have either the appearance
of warts or ﬂat scaly red–brown macules, resemble lesions of
pityriasis versicolor or pityriasis rosea .The ﬁrst type of lesion
is usually caused by the same HPV types as those found in ﬂat
warts in the general population (e.g HPV-3 and 10), while the
second one is usually caused by EV HPV types (e.g HPV-5, 8,
9, 12, 14, 15, 17, 19–25, 28, 29, 36–38, 47, 49, 50) (Penneys,
1997; Lowy et al., 2003; Odom et al., 2000; Ostrow et al.,
1987; Pﬁster, 1987; Yutsudo et al., 1994). There may be more
then one HPV type in the same patient (Ostrow et al., 1987;
Pﬁster, 1987).
The pathogenesis of this syndrome is unknown but is felt to
be a speciﬁc defect of cell mediated immunity (Penneys, 1997;
Lowy et al., 2003; Odom et al., 2000; Majewski et al., 1986).
Some EV patients are at high risk of developing cutaneous
squamous cell carcinoma (Sterling and Kurtz, 1998; Penneys,
1997; Lowy et al., 2003; Odom et al., 2000; Orth, 1986).
Although, pityriasis like lesions caused by any EV type may
be at increased risk of becoming malignant, the risk appears
to be greatest for those caused by HPV-5, 8 and 47 types
(Sterling and Kurtz, 1998; Penneys, 1997; Lowy et al., 2003;
Odom et al., 2000; Pﬁster, 1987; Orth, 1986).
The lesions of individuals with EV who have only ﬂat warts
caused by non-EV HPV types do not seem to be at increased
risk of becoming malignant. Squamous cell carcinomas devel-
op in 30–60% patients. Most often, skin cancers appear on
sun–exposed surfaces, but they can appear on any part of
the body. They begin to appear at ages 20–40. HPV-5, 8 and
47 are found in more than 90% of EV skin cancers. The squa-
mous cell carcinoma may appear denovo but usually appear
on the background of numerous actinic keratosis and lesions
of Bowen’s disease, locally and usually aggressive (Sterling
and Kurtz, 1998; Penneys, 1997; Lowy et al., 2003; Odom
et al., 2000; Sharquie et al., 2007).There is a high rate of registering records in the last two
decades of cases with clinical features almost similar to inher-
ited EV. These cases were exclusively kidney transplant pa-
tients with immunosuppressive drugs. This case controlled
study was designed to describe the clinical pictures of extensive
viral warts with skin malignancies in kidney transplant patients
in comparison with inherited EV features.2. Patients and methods
This case controlled study that included 130 patients (103
males and 27 females) with kidney transplantation was car-
ried out in kidney transplantation centers in Baghdad and
Al-Karma Teaching Hospitals, from December 2002 to Sep-
tember 2004. All recruited patients were receiving the immuno-
suppressive drugs after renal transplantation. They consisted
of rapidly decreasing doses of intravenous methylprednisolone
succinate for the ﬁrst 3 days followed by oral prednisolone,
tapered slowly to a maintenance dose of 10 mg/day or 20 mg
every other day by the end of the ﬁrst year. Azathioprine
was given at doses ranging form 1 to 4 mg/kg/day according
to the white blood cell count. Cyclosporine, in combination
with azathioprine was given orally starting with 8–10 mg/kg/
day, decreased every 2 weeks by 2 mg/kg/day to a maintained
dose of 5 mg/kg/day. History was taken from all patients
including age, sex and date of transplantation.
These patients were divided into three groups according to
the duration of kidney transplant: group A 1–10 years, group B
11–20 years and group C more than 20 years. Biopsies were
performed from the viral warts lesions and the associated
tumors.
Two hundred and sixty apparently healthy individuals, 206
males and 54 females had been examined as the control group
for the presence of viral warts and tumors. These control cases
had recruited randomly from the general population in multi-
ple regions in Baghdad.3. Results
Sixty-ﬁve patients (50%) out of 130 patients with kidney trans-
plantation had viral warts. The ages of these patients ranged
Table 1 Showing the demographic features of 65 (50%) patients out of 130 patients with kidney transplantation associated viral
warts.
Groups Duration of
kidney transplant
Mean ages of
patients
No. of patient
with viral warts
Location of
viral warts
BCC and
location
SCC and location
Group A 1–10 years 45.49 ± SD
10.82 years
28 (43.1%) Face and dorsa
of hands
Nil Two (7.1%) lower lip,
dorsum of hand
Group B 11–20 years 45.49 ± SD
10.82 years
30 (46.2%) Face and dorsa
of hands
One nose Two (6.6%) lower lip,
dorsum of hand
Group C More than 20 years 45.49 ± SD
10.82 years
7 (10.7%) Face and dorsa
of hands
Nil One (14%) lower lip
‘‘Acquired epidermodysplasia verruciformis’’ in kidney transplant patients 55from 20 to 71 years with a mean of 45.49 ± SD 10.82 years.
There were 51 males and 14 females with a male/female ratio
3.64:1. The duration of the warts ranged from 0.5 to 10 years
with a mean of 3.74 ± SD 2.67 years.
The distribution of patients with viral warts among the
groups was as follows: group A 28 (43.1%), group B 30
(46.2%) and group C 7 (10.7%) cases. So, 37 (57%) cases of
viral warts occurred after 11 years of kidney transplantation,
while, viral warts were seen in 10 (3.8%) individuals in the con-
trol group. There was statistically signiﬁcant difference be-
tween patients and control cases (P value <0.001).
Most of the viral warts were multiple and of the verrucae
vulgaris type.
Skin malignancies were observed in 6 (9.2%) cases of kid-
ney transplantation: 5 cases of squamous cell carcinoma and
one case of basal cell carcinoma. Squamous cell carcinomas
were mainly located on the lower lips in 3 cases and 2 on the
dorsa of hands, while basal cell carcinoma was observed on
the nose. Two cases (7.1%) of squamous cell carcinoma were
seen in group A, 2 (6.6%) in group B and 1 (14%) in group
C. One case of basal cell carcinoma was noted in group B.
No skin malignancies were observed in the control individuals.
Biopsies and histopathological examination of the viral and
skin tumors conﬁrmed the diagnosis (Table 1).
4. Discussion
Kidney transplant patients often have immunosuppression as a
result of the multiple immunosuppressive drugs that are used
to prevent organ rejections (Hamilton, 1988; Rowan et al.,
1988). This immunosuppression usually ends with increased
tendency for infections especially viral warts (Rowan et al.,
1988).
In the present work, viral warts had been observed in 50%
of kidney transplant patients in the ﬁrst 10 years of transplan-
tation, while it had been recorded in 90% within the ﬁrst
5 years of transplantation in other countries (Odom et al.,
2000; Rowan et al., 1988; Rudlinger et al., 1986; Leigh and
Glover, 1995a,b). So in Iraq, patients with kidney transplanta-
tions had a tendency to develop late onset viral warts when
compared with other countries, as 50% of patients with kidney
transplantations had their viral warts after 11 years of their
kidney transplant. Skin malignancies mainly squamous cell
carcinoma and basal cell carcinoma were seen in 6 (9.2%)
cases of kidney transplant patients with viral warts. In all
cases, these lesions were observed on the sun exposed areas
mainly the face. The increase in the rate of malignancies
among patients with kidney transplantations was similar towhat has been published (Odom et al., 2000; Rudlinger
et al., 1986; Leigh and Glover, 1995a; Sharquie and Al-Sadawi,
2001).
Inherited EV is usually an autosomal recessive disease, that is
associated with early onset of numerous viral warts similar to
pigmented pityriasis rosea or tinea versicolor like lesions (Ster-
ling and Kurtz, 1998; Penneys, 1997; Lowy et al., 2003; Odom
et al., 2000) with a high tendency to develop skin malignancies
especially squamous cell carcinoma in 30–60% of cases. They
begin to appear at ages 20–40 years (Odom et al., 2000; Sharquie
et al., 2007). Most of the malignant tumors remain local, but re-
gional and distant metastasis may occur (Sterling and Kurtz,
1998; Penneys, 1997; Lowy et al., 2003). The serotypes of HPV
that responsible for this oncogensity are 5, 8 and 47 types
(Sterling and Kurtz, 1998; Penneys, 1997; Lowy et al., 2003;
Odom et al., 2000; Pﬁster, 1987; Orth, 1986). In Iraq, there is a
focus of inherited EV as a result of inter-consanguineous mar-
riages. These cases are usually seen in Sammaraa City (100 km
North of Baghdad) (Sharquie et al., 2007; Al-Hamami et al.,
1986). The morphology of the rash is similar to that what had
been published, present in early childhood with pigmented pity-
riasis rosea or tinea versicolor like lesions on the sun exposed
parts of the body (Sterling and Kurtz, 1998; Penneys, 1997;
Lowy et al., 2003; Odom et al., 2000; Sharquie et al., 2007).
They are usually associated with skin malignancy but in Ir-
aqi cases, these tumors are usually were aggressive and had a
high tendency to regional metastasis as we observed (Sharquie
et al., 2007). Squamous cell carcinoma arising from per-orbital
viral warts that lead to orbital invasion and eye inoculation
(Sharquie et al., 2007).
It is well known that EV associated with skin malignancies
like squamous cell carcinoma and basal cell carcinoma and
HPV types 5, 8 and 47 have been incriminated in their etiopatho-
genesis (Sterling and Kurtz, 1998; Penneys, 1997; Lowy et al.,
2003; Odom et al., 2000; Pﬁster, 1987; Orth, 1986). Most re-
cently, it has been observed that HPV had contributed in the
development of squamous cell carcinoma even in patients with-
out viral warts (Kazutoshi et al., 2004; De-Jong Tieben et al.,
1995). So, HPV in patients with kidney transplant could act as
a co-factor in the tumor development along with immunosup-
pression, solar radiation and other environmental factors
(Sterling and Kurtz, 1998; Penneys, 1997; Lowy et al., 2003;
Odom et al., 2000; Leigh and Glover, 1995b).
In reviewing, the clinical picture of the inherited EV in com-
parison with that of the clinical features in patients with kidney
transplant, we found the following similar observations in both
conditions: there is immunosuppression because of impaired
cell mediated immunity, the rash occurs in young patients,
56 K.E. Sharquie et al.there are numerous skin lesions, they are recalcitrant to ther-
apy, viral warts and skin cancers occur on any part of the body
especially in sun exposed areas of the body and skin malignan-
cies are a common feature (Sterling and Kurtz, 1998; Penneys,
1997; Lowy et al., 2003; Odom et al., 2000; Ostrow et al., 1987;
Pﬁster, 1987; Yutsudo et al., 1994; Majewski et al., 1986; Orth,
1986; Hamilton, 1988; Sharquie and Al-Sadawi, 2001; De-Jong
Tieben et al., 1995; Annelies et al., 2002; Jeffrey et al., 2000;
Shamanin et al., 1994).
So, the infective agent, the immune defect, clinical pictures
of the skin rash and the course of the disease in kidney trans-
plant patients having many similarities with that of the
inherited form of EV (Leigh and Glover, 1995a,b; Sharquie
and Al-Sadawi, 2001; Kazutoshi et al., 2004; De-Jong Tieben
et al., 1995; Annelies et al., 2002; Jeffrey et al., 2000; Shamanin
et al., 1994). Accordingly, we think that the clinical features in
patients with kidney transplant deserve the term acquired epi-
dermodysplasia verruciformis.
In conclusion, patients with kidney transplantation had a
high frequency of viral warts and skin malignancy in the ex-
posed parts of the body and these might simulate EV.
Also, we describe a disease in kidney transplants patients
that have many similarities with inherited type of EV that de-
serve the term acquired epidermodysplasia verruciformis form.
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